EF
FLGT icon

Empowered Funds’s Fulgent Genetics FLGT Stock Holding History

Empowered Funds’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,670
Closed -$383K – 1788
2025
Q1 		$383K Sell
22,670
-72,341
-76% -$1.23M 0.01% 1322
2024
Q4 		$1.75M Buy
95,011
+4,609
+5% +$90K 0.03% 787
2024
Q3 		$1.96M Buy
90,402
+4,556
+5% +$102K 0.03% 681
2024
Q2 		$1.68M Sell
85,846
-23,321
-21% -$487K 0.03% 664
2024
Q1 		$2.37M Buy
109,167
+8,225
+8% +$204K 0.04% 550
2023
Q4 		$2.92M Buy
100,942
+9,024
+10% +$241K 0.07% 391
2023
Q3 		$2.46M Buy
91,918
+7,426
+9% +$254K 0.07% 393
2023
Q2 		$3.13M Buy
+84,492
New +$2.95M 0.11% 252

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Empowered Funds's FLGT Position: Q2 2025 in Review

Empowered Funds sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 22,670 shares — an estimated $383K sold.

Empowered Funds first reported a position in FLGT in Q2 2023 and held it in 8 quarters. The position peaked at $3.13M in Q2 2023. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

  • Empowered Funds reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
  • Empowered Funds sold 22,670 Fulgent Genetics shares in Q2 2025, an estimated $383K.
  • Empowered Funds first reported a position in Fulgent Genetics in Q2 2023 and held it in 8 quarters.
  • Empowered Funds's Fulgent Genetics position peaked at $3.13M in Q2 2023.
  • 167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on Empowered Funds's 13F filing for Q2 2025, filed 11 Aug 2025.